Development of Kaposi's sarcoma in an AIDS patient after treatment with topical tacrolimus [1]

Journal of the American Academy of Dermatology

Volumn 50, Issue 1, 2004, Pages 149-150

  Cho, Mimi ^a   Puma, Insley ^a   Nguyen, Diana ^a   Schut, Ronald ^b   Glesne, Lynn ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ; LAMIVUDINE; STAVUDINE; TACROLIMUS;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; CLINICAL ARTICLE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN TISSUE; KAPOSI SARCOMA; LETTER; MALE; PRIORITY JOURNAL; PSORIASIS; SEBORRHEIC DERMATITIS; SKIN BIOPSY;

EID: 0347634486     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(03)02145-5     Document Type: Letter

References (2)

1. Geraminejad P, Memar O, Aronson I, Rady PL, Hengge U, Tyring SK. Kaposi's sarcoma and other manifestations of human herpes-viruses 8. J Am Acad Dermatol 2002;47:641-55.
2. Alle DM, Esterly NB. Significant systemic absorption of tacrolimus after topical application in a patient with lamellar ichthyosis. Arch Dermatol 2002;138:1259-60.